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Neural plateIn amphibian embryos, our previous work has demonstrated that calcium transients occurring in the dorsal
ectoderm at the onset of gastrulation are necessary and sufﬁcient to engage the ectodermal cells into a neural
fate by inducing neural speciﬁc genes. Some of these genes are direct targets of calcium. Here we search for a
direct transcriptional mechanism by which calcium signals are acting. The only known mechanism responsible
for a direct action of calcium on gene transcription involves an EF-hand Ca2+ binding protein which belongs to
a group of four proteins (Kcnip1 to 4). Kcnip protein can act in a Ca2+-dependentmanner as a transcriptional re-
pressor by binding to a speciﬁc DNA sequence, the Downstream Regulatory Element (DRE) site. In Xenopus,
among the four kcnips, we show that only kcnip1 is timely and spatially present in the presumptive neural
territories and is able to bind DRE sites in a Ca2+-dependent manner. The loss of function of kcnip1 results in
the expansion of the neural plate through an increased proliferation of neural progenitors. Later on, this leads
to an impairment in the development of anterior neural structures. We propose that, in the embryo, at the
onset of neurogenesis Kcnip1 is the Ca2+-dependent transcriptional repressor that controls the size of the neural
plate.
This article is part of a Special Issue entitled: 13th European Symposium on Calcium.
© 2014 Published by Elsevier B.V.1. Introduction
Calcium (Ca2+) signaling plays an essential role throughout verte-
brate development, from fertilization to organogenesis. In particular,
Ca2+ ﬂuxes have been implicated in dorsal–ventral axis establishment,
convergence extensionmovements [1,2] and in neuronal differentiation
during neural tube closure [3,4]. Furthermore, Ca2+ is required for the
speciﬁcation of the vertebrate embryonic nervous system during neural
induction [5–7].
Neural induction occurs in the dorsal ectoderm at the onset of
gastrulation. This process is controlled by morphogens secreted by the
dorsal mesoderm like Noggin, Chordin, Follistatin, Xnr3 and Cerberus,
which antagonize bone morphogenetic protein (BMP) signaling [8].
We have previously demonstrated that neural induction is associated
with transient increases in intracellular Ca2+, resulting from theopean Symposium on Calcium.
3, Centre de Biologie du
se, Cedex 04, France. Tel.: +33
erc).activation of L-type Ca2+ channels. These intracellular Ca2+ increases
are necessary and sufﬁcient to engage the ectodermal cells into a neural
fate, inducing proneural genes such as zic3 [5,9].
Through a differential screening between naive and Ca2+-stimulated
ectoderms we have isolated genes encoding transcriptional regulators
and RNA binding proteins downstream of the Ca2+ signaling pathway
[10–13]. Among the isolated genes we demonstrated that the arginine
methyltransferase prmt1b acts as an early proneural gene that regulates
zic3 transcription. Interestingly, prmt1b expression is a direct Ca2+ target
that does not require de novo protein synthesis [11].
Actually the only known direct Ca2+-dependent transcriptional
regulation occurs via the Ca2+ sensor DREAM (DownstreamRegulatory
Element Antagonist Modulator). The DREAM protein, also called
calsenilin, KChIP-3 or Kcnip3, is a EF-hand Ca2+ binding protein which
belongs to a group of four proteins that regulate the membrane
expression and the gating of Kv4 potassium channels [14]. Interestingly,
this protein is also able to bind to speciﬁc DNA sequence; the DRE
(Downstream Regulatory Element) site. The afﬁnity of DREAM to the
DRE is modulated by the Ca2+ occupancy of its EF-hand sites. DREAM
acts in a Ca2+-dependent manner as a transcriptional repressor [15,16]
or activator [17,18].
2078 I. Néant et al. / Biochimica et Biophysica Acta 1853 (2015) 2077–2085To simplify, hereafter we will use the kcnip acronym to refer this
family of Ca2+ sensors. In mammals, the four Kcnips (Kcnip-1 to -4)
are predominantly expressed in speciﬁc neuronal regions of adult
brain in rodent and human [19–21]. They are also found in nonneural
tissues including, the thyroid gland [22,23], the hematopoietic progeni-
tor cells [24] and the T and B lymphocytes [25,26].
There is no data concerning Kcnip expression during neural induc-
tion in vertebrates. In the mouse, kcnip3 transcript is detected at E10.5
[27] which occurs 3 days after neural induction and kcnip1, 2 and 4
are not detected before E13 [19]. In the ﬁsh Danio rerio, the embryonic
expressions of kcnip1b and 3 are detectable not before somitogenesis
[28].
In this article we ask if in the amphibian Xenopus laevis, Kcnip family
members are important transcriptional regulators during neural induc-
tion. We have determined that only kcnip1 is timely and spatially pres-
ent in the presumptive neural territories. The loss of function of kcnip1
impairs the development of anterior neural structures, which reveals
a functional involvement of the Kcnip family member in early
neurogenesis. In addition, we have shown that Xenopus Kcnip1 is able
to bind DRE sites in a Ca2+-dependent manner and to control the pro-
liferation of neural progenitors. We propose that Kcnip1 is a Ca2+-
dependent transcriptional repressor that participates in the regulation
of the neural plate expansion at the origin of the nervous system in
Xenopus embryo.
2. Material and methods
2.1. Embryos
X. laevis embryos were obtained and staged using standard proce-
dures [11,29]. Embryoswere raised in 0.1XNormal AmphibianMedium.
2.2. Constructs, mRNA, morpholino microinjections
Plasmids containing the four full length clones for X. laevis kcnips
(kcnip1 to 4) were obtained from different libraries (Table S2). Kcnip1
was PCR-introduced into pCS2 or in frame with GFP into pCS2-GFP
vectors (Forward 5′-CGGATCCATGGGAGCAGTGATGG-3′; Reverse 5′-
CGAATTCCTACATCACATTTTC-3′), at BamHI and EcoRI restriction sites,
underlined, with or without stop codon, in bold). For in vivo experi-
ments, mRNAs were synthesized using the mMESSAGE mMACHINE
kit (Ambion) from NotI-linearized plasmids. For microinjections 6 ng
of kcnip1-GFPwere injected per blastomere. The anti-sense morpholino
oligomers to block kcnip1 translation were chosen in the proximal 5′
UTR sequence between −41 and−17 nt (MoK1a, sequence 5′-GTTT
TGTTTAATCTCCCTCGAATGC-3′), or including the start codon (in bold)
between −2 and +23 nt (MoK1, 5′-AACGTGCCCATCACTGCT
CCCATGT-3′), respectively (Gene Tools). Control morpholino was pro-
vided by the manufacturer (MoC, 5′-ATGGAGGCAACTGTCGTCGCTA
CGA-3′). A total of 6 ng of morpholinos was injected per embryo. To
identify the injected side GFP mRNA (50 pg) or nlacZ (200 pg) were
used as tracers. The lacZ expression was revealed with the Red-Gal
substrate (Research Organics).
2.3. RT-PCR, in situ hybridization, immunohistochemistry
RT-PCR analysis was performed on RNAextracts from staged embry-
os as described [12]. For the separation of the outer and inner layers, ec-
toderm explants were isolated from stage 10 embryos and transferred
to Ca2+ andMg2+ freemedium [30]. This resulted in the disaggregation
of the inner layer cells, whereas the outer layer cells remained intact,
facilitating the separation between the two layers. Primer pairs are
presented in Table S3. Whole-mount ISH was carried out according to
[31]. For kcnip1 anti-sense and sense digoxigenin-labeled probes were
respectively synthesized by T7 and SP6 RNA polymerases (Promega),
with the full length cDNA kcnip1 used as template. The other plasmidsused as templates were prmt1b, zic3, sox2, sox8, n-tubulin, pax6,
p27xic1, k81 and myod (Table S4). Stained embryos were then embed-
ded in 3% lowmelting agarose for vibratome sectioning. For immunohis-
tochemistry analysis, in vivo expression of GFP signalswas performed on
embryos ﬁxed at stage 9 or stage 14 [13]. The proliferative cells were
stained with anti-phospho-Histone 3 (Ser10) anti-body (1/1000e, Up-
state) and revealed using an Alexa-555-coupled secondary anti-body
(Fisher Scientiﬁc). Nuclei were counterstained with To-Pro3 (1/1000,
Molecular Probes). Fluorescent images were obtained using confocal
facilities (Leica SP2).
2.4. EMSA and Western blot
Electrophoretic mobility shift analysis was performed as described
[32,33] using double-stranded oligonucleotide 32P labeled probe
encompassing the mouse NCX3 DRE double site (DRE) 5′-GGCTTGTCA
GTCAGTGCGG-3′ (underlined) and the mutated DRE site (mDRE) 5′-
GAAGCCGGAATAAAGGAGGCCCCTG-3′ (in bold). Xenopus nuclear ex-
tracts were prepared from control and microinjected embryos at stage
9 or stage 14 according to [32]. Nuclear proteins (30 μg quantiﬁed by
Bradfordmethod, Bio-Rad kit) were incubated 20minwith the radioac-
tive probes, in the presence of 10 μM of EGTA or CaCl2. For cold DNA
competition, a 20-fold excess of unlabeled double-stranded oligonucle-
otide was added 10 min before the labeled probe. Protein–DNA com-
plexes were resolved in 5% nondenaturing polyacrylamide gels and
visualized by autoradiography. For Western blot analysis, control and
microinjected embryos were lysed at stage 13 and 10 K supernatants
equivalent to 1 embryo and were applied on SDS-PAGE as described
[13]. The GFP and Kcnip1-GFP proteins were revealed by immunoblot-
ting with rabbit anti-GFP polyclonal antibody (1/5000, TP401, Torrey
Pines, Clinisciences) and goat peroxidase-conjugated anti-rabbit anti-
body (1/5000, Promega) was detected with the enhanced chemilumi-
nescent kit (ECL, Amersham).
3. Results
A DRE-binding activity is present at blastula and neurula stages in Xenopus
embryos
The four Kcnipmembers are capable of bindingDNA at DRE sites in a
Ca2+ dependent manner [16] and make the direct link between Ca2+
increase and transcription [15,34]. We thus hypothesized that a DRE-
binding activity could be present in the early ectoderm to transform
the Ca2+ signaling into transcriptional activation. To test this, we
performed electrophoretic mobility shift analysis (EMSA) using nuclear
extracts from embryos at blastula (stage 9) or at early neurula
(stage 14) with double-stranded oligonucleotide encompassing the
mouse NCX3-DRE site [35]. DRE-retarded bands were observed in
stage 9 and stage 14 embryos extracts with the NCX3-DRE consensus
probe (Fig. 1A, lanes 2 and 6 respectively). The retarded bands were
competed with 20-fold excess of a cold NCX3-DRE probe (Fig. 1A,
lanes 3 and 7) and affected by the mutated-DRE site (Fig. 1A, lanes 5
and 8 respectively). Furthermore for stage 9 nuclear extract, this
binding was signiﬁcantly decreased in the presence of 10 μM CaCl2
(Fig. 1A, lane 4), as initially established in the case of mammalian
KCNIP3 [15]. These data suggest that blastula and neurula stage
X. laevis embryos contain a Ca2+-dependent DRE-binding activity that
corresponds to DRE-binding Kcnip speciﬁcity. In addition, in silico
analysis reveals potential DRE sites in the proximal 5′UTR of prmt1
gene from X. laevis (accession number BC054955) in sense orientation
at −40 nt position and anti-sense orientation at −6 nt position
from the AUG codon (Fig. 1B). A putative DRE binding site was also
found in the anti-sense orientation at the most proximal position
(−5 nt) of prmt1 gene from Xenopus tropicalis (accession number
NM_001005629). Furthermore two important genes involved in the
control of neural progenitors proliferation, foxm1 and sox2, also present
Fig. 1. Characterization of DRE binding sites in nuclear extracts and temporal expression of kcnips family in Xenopus laevis. (A) Electrophoreticmobility shift assay (EMSA). (Lane 1, *) cor-
responds to free mouse NCX3 DRE oligonucleotide labeled with 32P. When incubated in the presence of nuclear extracts from Xenopus embryos at stage 9 (lane 2,) or at stage 14
(lane 6) the DRE probe is retarded (arrow). Competition with 20-fold of cold NCX3 DRE oligonucleotide (lane 3, stage 9; lane 7, stage 14) or with 10 μM CaCl2 (lane 4, stage 9) inhibits
the binding reaction. The retarded band was affected when Xenopus extracts were incubated in the presence of mutated DRE oligonucleotide (lane 5, stage 9; lane 8, stage 14, #).
(B) Putative DRE sites present in prmt1, foxm1 and sox2 5′UTRs from Xenopus laevis (X laevis) and Xenopus tropicalis (X trop). Arrows indicate the DRE sequence orientation.
(C) Temporal expression of kcnip in Xenopus laevis embryos. RT-PCR using total RNA from Xenopus laevis embryos extracts and speciﬁc primers for the different kcnip. Extractions were
done from fertilized to tadpole stages (stages indicated according to [29]). Odc used as housekeeping gene.
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in the close proximal position is found in foxm1 gene from X. laevis
(AJ853462) in sense orientation at −5 nt from ﬁrst codon and from
X. tropicalis (XM_004912735) in anti-sense orientation at −3 nt. A
second anti-sense DRE site is present upstream in X. tropicalis foxm1 at
−80 nt. Sox2 gene exhibits potential DRE sequence in relative more
distal positions,−220 nt and−157 nt in X. laevis (NM_001088222),
and−236 nt,−175 nt and−50 nt in X. tropicalis (NM_213704).
3.1. Identiﬁcation of Kcnip family in X. laevis
In order to characterize the molecular element responsible for the
DRE binding activity, we screened available databases to ﬁnd the
X. laevis Kcnips by homology with mammalian sequences. In mammals,
the four kcnip family genes encode several protein isoforms, which
differ in their N-termini depending on the alternative promoter and
splicing use [19] whereas the C-termini are more identical and contain
the dimerization domain, the EF-hands Ca2+ binding sites motifs and
the residues involved in DNA sequence recognition [36]. Predicted
sequences concerning X. laevis were extracted from Xenbase and NCBI
libraries. The putative deduced Kcnip members of X. laeviswere aligned
with the human and mouse protein orthologs (Fig. S1). The entire C
terminal sequences that comprise the 4 EF-hands (boxes in gray) are
well conserved, and sequence variationsmainly concern theN terminus
domain. We were able to attribute each sequence issued from X. laevis
databases to the nearest isoform determined by the alignment with
mammalian sequences, and to conﬁrm the annotation we here adopted
for Xenopus Kcnips according to the nomenclature (http://www.
xenbase.org). Full length cDNA BC074264 supports the Kcnip1 isoformencoded by kcnip1-Ib variant (Fig. S1A), and full length cDNA BC097806
displays highest homology to kcnip4-Ie variant (Fig. S1D). A partial
sequence for kcnip3 variant was found in databases (DC056397) and cor-
responds to kcnip3-Ib variant encoding a type 2 isoform (Fig. S1C). Kcnip2
identiﬁcation from Xenbase is contained by the cDNA referred to
BC082465 (Fig. S1B). To summarize these alignments, the highest
similarities in amino acids restricted to ORFs are given in Table S1 and
only the closest isoform of each respective member in the Kcnip family
is considered here. According to a high degree of homology, even with
the exception of Kcnip2 bearing only 71% identities to mammals, all
these X. laevis predictive proteins belong to the Kcnip family (Table S1).
A phylogenetic tree was constructed with the Phylip Neighbor-
joiningmethod (Fig. S2), wherewe introduced the predictive Kcnip iso-
forms issued from amphibians, zebraﬁsh and chicken, with human and
mouse proteins. The ﬁrst appearance of Kcnips in evolution concerns
the insect phylum, with a unique Kcnip related protein in Drosophila
melanogaster harboring about 40% identity with the mammals [37].
X. laevis Kcnip1, 3 and 4 are indeed related to their respective subgroup
except for X. laevis Kcnip2 which shows proximity with Kcnip1 se-
quence. For synteny analysis, we examined from databases the genomic
regions containing Kcnips. The close neighbor genes ﬂanking Kcnip
orthologs are mainly conserved between human, mouse, chicken,
X. tropicalis and X. laevis genomes, despite less information concerning
the last species (Fig. S3). The 3′ ﬂanking region for Xenopus Kcnip1 dif-
fers from those for human, mouse or chicken downstream to Tlx3.
X. tropicalis kcnip2 region is more closely related to Gallus KCNIP2.
The proposed position of kcnip2 in X. laevis genome is misleading,
conﬁrming the ambiguity for this gene in this species. Surprisingly no
KCNIP3 gene is found in chicken. The 5′ ﬂanking genes upstream to
2080 I. Néant et al. / Biochimica et Biophysica Acta 1853 (2015) 2077–2085PROM2 and KCNIP3 differ between mammals and amphibians. KCNIP4
orthologs are positioned in comparable genomic regions that contain
very few ORFs.
3.2. Temporal expression of kcnip1 during Xenopus development
To investigate the temporal expression pattern of the X. laevis kcnip
members, speciﬁc primers were chosen for the putative variants ac-
cording to Table 1. RT-PCR on RNAs extracted from X. laevis embryos
are shown in Fig. 1C. The Kcnip1 homolog is expressed in all stages
throughout embryonic development, from fertilized egg (stage 1) to
tadpole stages (stage 46). The transcripts for kcnip3 and kcnip2 are
expressed far after neural induction, at stage 21 and stage 25 respective-
ly. Kcnip4 is not ampliﬁed before stage 46. Since the temporal expres-
sion pattern of kcnip1 is compatible with a role in neural induction in
X. laevis, we focused on kcnip1 for further functional analysis.
3.3. Spatial expression pattern of kcnip1 revealed strong expression in
neural territories
The spatial expression pattern of kcnip1 was analyzed by whole
mount in situ hybridization (ISH). Maternal mRNA is localized in the
animal blastomeres during the cleavage stages (Fig. 2A1, A2). After the
zygotic transcriptional switch at midblastula, kcnip1 is expressed at
the onset of gastrula throughout the animal pole; in the ectoderm and
mesoderm (Fig. 2B–C). To better investigate kcnip1 expression during
gastrulation we performed ISH on sections of gastrula embryos (stage
10.5). As shown in Fig. 2C, the expression of kcnip1 can be detected in
both the ventral and dorsal ectoderm and mesoderm; no staining was
detected in the endoderm. To further analyze kcnip1 expression in the
ectoderm, we have isolated the superﬁcial outer layer (nonneuronal ep-
ithelial layer) from the deep inner layer (the sensorial neuroectoderm
layer) of isolated ectoderm excised at early gastrula (stage 10) and an-
alyzed in both layers kcnip1 mRNA expression by RT-PCR. Kcnip1
mRNA is found in both the outer and the inner layers (Fig. S4). During
neural tube closure stage (stage 18), kcnip1 is highly expressed in the
neural folds (Fig. 2D) where a strong signal was observed in the most
anterior part from which the entire brain will develop. CentralTable 1
Quantiﬁcation of the anterior expression domain expansion of prmt1b in MoK1 and
MoC-injected embryos.
a (arb.units)⁎ b (arb.units)§ Ratio a/b Mean
MoK1
Embryo number #1 6.5 5 1.30 1.294 + 0.176
#2 7 4.5 1.55
#3 6 5.5 1.09
#4 7 6 1.17
#5 6.5 6 1.08
#6 7 5 1.40
#7 7 4.5 1.55
#8 7 6 1.07
#9 8.5 5.5 1.55
#10 6.5 6 1.08
MoC
Embryo number #1 6 6.5 0.92 1.047 + 0.073
#2 6 6 1
#3 6.5 6 1.08
#4 6.5 6.5 1
#5 6.5 5.5 1.18
#6 5.5 5 1.1
Mean are given + mean deviation.
arb.units; arbitrary units.
⁎ This value corresponds to the width of the anterior expression domain of prmt1b on
the MoK1-injected side.
§ This value corresponds to the width on the uninjected side, as shown in Fig. 2A.transverse sections of sibling stage clearly highlight the expression
pattern in the neuroepithelium tissue and in the somitic mesoderm
(Fig. 2E). Notochord was faintly marked.
During organogenesis, kcnip1 is expressed at a high level in neural
structures (stage 33/34, Fig. 2F). Indeed, all the developing central ner-
vous system (CNS)was strongly stained, from the anterior to the posteri-
or, namely the telencephalon, themesencephalon, the rhombencephalon,
and the spinal chord (Fig. 2F and insert). Sensory neurogenic placodes,
including the olfactory gland, the ocular vesicle, the otic vesicle, the
cranial ganglia and the branchial archeswhich originate from the neural
crest, also expressed a high level of kcnip1mRNA. Mesodermal expres-
sion is lower compared with the neural one, restricted to the inter-
somitic structures, and to the pronephros. No staining was seen in the
cement gland and in the endodermal derivatives. Transverse sections
at the head and trunk levels conﬁrm the speciﬁc expression of kcnip1
in the CNS, highly present in the diencephalon and neuroretina
(Fig. 2F1) and in the spinal chord (Fig. 2F2). The kcnip1 transcript
exhibited a low but signiﬁcant expression in the pronephric tubule
and its expression disappeared from the notochord (Fig. 2F2). The
robust spatial and temporal kcnip1 expressions during the early devel-
opment in Xenopus embryos suggest a function for kcnip1 during early
neurogenesis.
3.4. Knockdown of kcnip1 suppresses the DRE-binding activity at blastula
and neurula stages
To study the function of Kcnip1 as a DRE-binding transcriptional
regulator we constructed a GFP-tagged kcnip1 (kcnip1-GFP) and used
morpholino anti-sense oligonucleotide which blocks the initiation
of translation of kcnip1 (MoK1). First we veriﬁed the subcellular
localisation of kcnip1-GFP. The kcnip1-GFP mRNA was injected in
2-cell stage embryos and the fusion protein was visualized by confocal
microscopy. In ectoderm cells at blastula stage, Kcnip1-GFP is localized
at the plasma membrane, in the cytoplasm and in the nucleus (Fig. 3A,
left panel). The nuclear localisation of Kcnip1-GFPwas conﬁrmed by la-
beling the nuclei with the DNA-intercalating molecule To-Pro (Fig. 3A,
middle and right panels). These results are in accordance with the sub-
cellular distribution of the Kcnip1 counterpart in mammalian cell cul-
tures [38]. In addition, the nuclear localization of the GFP-tagged
Kcnip1 is in agreement with a role for Kcnip1 as transcriptional regula-
tor in X. laevis embryos. The effect of MoK1 in blocking translation was
conﬁrmed by Western blot experiments. Embryos at the 2-cell stage
were co-injected with kcnip1-GFP mRNA and MoK1 or a scramble
control morpholino (MoC). The expression of the Kcnip1-GFP protein
was totally abolished in MoK1-injected embryos compared with
MoC-injected embryos (Fig. 3B). The DRE-binding activity of MoK1-
injected embryos was tested by EMSA (Fig. 3C). Incubation of the DRE
probe with nuclear extracts revealed that the binding is strongly
decreased with nuclear extracts from MoK1 morphants at blastula
(stage 9) or early neurula (stage 14) (Fig. 3C, lanes 2 & 5 respectively),
compared with MoC-injected embryos (Fig. 3C, lanes 1 & 4, respective-
ly). This effect was further conﬁrmed with a second morpholino anti-
sense oligonucleotide (MoK1a) targeting the 5′UTR of kcnip1 (Fig. 3C,
lanes 3 & 6). These data suggest that Kcnip1 is responsible for the
DRE-binding activity in Xenopus embryo during gastrulation.
3.5. Suppression of kcnip1 expands the neural plate at the expense of
epidermis
We demonstrated previously that Ca2+ signaling, restricted to
neural territories during gastrulation, controls the expression of early
neural genes including prmt1b and zic3 [5,11]. To investigate if Kcnip1
controls the expression of these early neural genes, we injected MoK1
into one dorsal blastomere at the 8-cell stage with nLacZmRNA as a lin-
eage tracer. Targeting the morpholino to one dorsal blastomere leaves
one half of the embryo as an uninjected control and insures that only
Fig. 2.Kcnip1mRNA distribution duringXenopus embryonic development. (A)Maternal expression at stage 6.5. (A1) Animal pole view showing expression in themicromeres. (A2) Lateral
view; the macromeres do not express kcnip1. (AP) animal pole, (VP) vegetal pole. (B) At gastrula stage (stage 10.5) kcnip1 is expressed in the dorsal ectoderm (ect). Dorsal to the top,
dashed line and arrow: blastoporal lip (bp). (C) In the corresponding gastrula sagittal section, kcnip1 mRNA is expressed in ectoderm (ect) and mesoderm (mes); and endoderm
(endo) is not labeled. Blastoporal lip is indicated by arrow. (D) Anterior view of a late neurula, kcnip1 is expressed in the whole neural plate. (E) Transverse section of (D) showing a
high expression of kcnip1 in the neural groove (ng), the closing neural tube (cnt) and somitic mesoderm (sm). Arch, archeteron, n, notochord. Bar for A, B, C, D, E 0.5 mm. (F) Lateral
view of stage 33/34 larvae and detail of the anterior part. Kcnip1 is strongly expressed in the different structures of the central nervous system (forebrain, midbrain, rhombomeres), in
the spinal chord (sp) in the eyes (e), also in branchial arches (ba), in intersomitic structures (s) and in pronephric tubules (pt). Kcnip1 is not expressed in the cement gland (cg). Bar
1 mm. F1 and F2 transverse sections at the indicated levels visualize kcnip1 expression in the diencephalon (Di), in the spinal chord and pronephric tubules, and n notochord. Bar F1
and F2: 0.2 mm.
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Fig. 3. Localization of Kcnip1, effect ofmorpholino on kcnip1 translation andDRE binding activity. (A) Confocal imaging of double labeled ectodermcell dissected at stage 9 over expressing
Kcnip1-GFP (in green, left panel), and the nucleicmarker ToPro3 (in red,middle panel). Themerge imaging shows a co-localization of these two probes (merge, right panel). Arrows point
nuclei. (B) Morpholino MoK1 blocks Kcnip1-GFP translation. Morpholino efﬁciency was veriﬁed by Western blot with an antibody against GFP on stage 13 lysates from whole embryos
injectedwith kcnip1-GFP. Anti-α-tubulin attests equivalent loading. Control corresponds to uninjected embryo extract (lanes 1, 4, 7). Embryos were injected at stage 2with 6 ng of control
morpholino (MoC, lanes 2, 3) or with 6 ng of morpholino against Kcnip1 (MoK1, lanes 5, 6), and with 50 pg of GFPmRNA (GFP, lanes 3, 6) or with 6 ng of kcnip1-GFPmRNA (Kcnip1-GFP,
lanes 2, 5) respectively. The GFP protein is expressedwhatever themorpholino used, whereasMoK1 (lane 5) but not MoC (lane 3) inhibits Kcnip1-GFP translation. (C)MorpholinoMoK1
reduces DRE binding activity. The DRE probewas submitted to EMSA after incubationwith Xenopusnuclear extracts fromMoC injected embryo at stage 9 (lane 1,MoC) or stage 14 (lane 4,
Moc), or from MoK1 injected at stage 9 (lane 2, MoK1) or stage 14 (lane 5, MoK1), or from morpholino targeting 5′UTR kcnip1 (MoK1a) at stage 9 (lane 3, MoK1a) or stage 14 (lane 6,
MoK1a) demonstrating that MoK1 signiﬁcantly inhibits the DRE binding activity due to Kcnip1.
2082 I. Néant et al. / Biochimica et Biophysica Acta 1853 (2015) 2077–2085the neural contribution of Kcnip1 is invalidated without affecting any
mesodermal activity [39]. Suppression of Kcnip1 by MoK1 resulted in
a signiﬁcant increase in prmt1b (79%, n = 29) and of its downstream
target zic3 (88%, n = 35) in the anterior neural plate at stage 16, as
shown by ISH (Fig. 4). By contrast, MoC had no effect on prmt1b or
zic3 expression (Fig. 4). This enlargement was quantiﬁed by the
ratio of the width of the anterior expression domain of prmt1b on the
MoK1-injected side relative to the uninjected side of neurula stage
embryos (Fig. 4 and Table 1). Injection of MoK1 into one dorsal blasto-
mere of an 8-cell embryo caused a 30% (n = 10) increase of prmt1b
expression domain compared with MoC-injected embryos. Kcnip1,
when bound to DRE sites is a transcriptional repressor. Therefore,Fig. 4.Kcnip1 invalidation impairs neural progenitor fate. Kcnip1 invalidationwas performedby
neurula stage, on injected side (right panels), with a signiﬁcant percentage for the extension of t
sox2 (85%, n = 17/20). Conversely, the neural crest marker sox8 is reduced (88%, n = 15/17),
markermyod is unaffected (80%, n = 4/5). Control morpholino MoC has no effect (upper pane
(30%, n = 10) was measured as the ratio of a/b. The same measurement was done for MoC injthe reduction of Kcnip1 protein by morpholino injection leads to a
diminished transcriptional repression. As a direct consequence, this
induces the increase in the transcription of its target genes such as
prmt1b.
Sox2 is a member of SoxB1 subgroup of transcription factors known
to control neural progenitor proliferation [40]. Like for prmt1b and zic3,
injection of MoK1 induced a signiﬁcant increase in sox2 mRNA (85%,
n = 20). This expansion of the neural plate is accompanied by a reduc-
tion of the neural crest cells marker sox8 expression (88%, n = 17) and
by a lateral shift of the epidermal marker k81 (91%, n = 11). No appar-
ent change was observed for the expression pattern of earliest muscle-
speciﬁc markermyod. This result demonstrates clearly that the increaseinjection ofMoK1 into D1blastomere at stage 3.MoK1 induces neural plate enlargement at
he expression pattern of proneural genes, prmt1b (79%, n= 23/29), zic3 (88%, n= 31/35),
the epidermal gene k81 is laterally shifted (91%, n = 10/11) and the early muscle speciﬁc
ls). The enlargement relative to the expression domain prmt1b of the MoK1-injected side
ected embryos (see details in text). Injected side on the left (red gal), bar scale: 0.5 mm.
Fig. 5. Kcnip1 invalidation triggers neural progenitor proliferation. (A) Confocal view of
neural plate of stage 14 embryo, MoK1-injected with GFPmRNA as tracer into one dorsal
blastomere of 8-cell embryos. GFP expression determines the injected area. Dividing
cells are revealed by immunohistochemistry with anti-pH3 antibody plus Alexa555.
The dashed line separates MoK1 injected and noninjected area. On each surface pH3
positive nuclei were counted and results were expressed in number of nuclei/mm2.
(B) Enhancement of cell proliferation in MoK1 injected embryos versus noninjected
sides was quantiﬁed by pH3 positive nuclei per mm2, signiﬁcant difference (p b 0.005).
No signiﬁcant difference in pH3 positive nuclei counting was found in MoC injected
embryo versus noninjected. (C) Down-regulation of Kcnip1 alters the expression of two
regulators of cell division. Expression of foxm1, a forkhead transcription factor required
for cell proliferation of neural precursors in Xenopus neuroectoderm is increased (right
panel) and the expression of p27xic1, a cyclin-dependent kinase inhibitor is reduced in
the anterior neural plate on the injected side (right panel) compared with the MoC
injected side (left panel) bar 0.5 mm.
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secondary effect resulting from impaired mesoderm induction. These
results suggest that kcnip1 participates in the control of the size of the
neural plate.3.6. Kcnip1 knockdown results in increased proliferation of neural
progenitors at neurula stage
We next asked whether kcnip1 loss-of-function expands the neural
plate by increasing the cell proliferation of neural progenitors. To
address this, we analyzed the mitotic cells in the neural plate of stage
14 embryos by immunostaining with anti-phosphorylated histone H3
(pH3) [41]. MoK1 or MoC were injected with GFP mRNA as a tracer
into one dorsal blastomere of 8-cell embryos and the number of pH3
positive cells counted (Fig. 5A). MoK1 caused a 1.6-fold increase in cell
proliferation over the control side (Fig. 5B, n = 7, p = 0.005). There
was no difference between the MoC and the uninjected side of the
control embryos (n = 3, p = 0.177, Fig. S3).
To further conﬁrm that Kcnip1 affects proliferation, we examined
whether it can alter the expression of two regulators of cell division.
Foxm1, a forkhead transcription factor required for cell proliferation of
neural precursors in Xenopus neuroectoderm [42] and p27xic1, a
cyclin-dependent kinase inhibitor, which is expressed in post mitotic
cells in the neural plate [43]. Embryos injected with MoK1 showed an
increase of foxm1 expression (85%, n = 7) and a reduction of p27xic1
expression (81%, n = 32) in the anterior neural plate on the injected
side (Fig. 5C). Altogether these data indicate that the early suppression
of kcnip1 provokes an enrichment of neural progenitors through the
stimulation of cell proliferation.
3.7. Loss of Kcnip1 results in the inhibition of neural differentiation and a
reduction of anterior neural structures and eye formation
In Xenopus neural plate, the over-expression of sox2 expands the
neural progenitor cell population and prevents their differentiation
[40,44,45]. Since we showed here that kcnip1 controls the expression
of sox2, we wanted to determine the effect of kcnip1 suppression
on neuronal differentiation. The expression of the neuronal marker
n-tubulin (n-tub) was analyzed by ISH at the neural tube closure
(stage 20). The anterior domain of n-tub expression pattern was
down-regulated in kcnip1morphants while the most posterior domain
is unaffected (88%, n = 25, Fig. 6A). To further analyze the effect of
kcnip1 loss-of-function on the anterior neural development, we per-
formed ISH for pax6, a homeobox transcription factor. At gastrulation,
the anterior expression domain of pax6marks the eye ﬁeld [46]. Injec-
tion of MoK1 in one dorsal blastomere of 8-cell embryos results in the
reduction of pax6 expression in the eye ﬁeld at neurula (86%, n = 15,
Fig. 6A) when compared with MoC injected embryos, suggesting
that the formation of the eye ﬁeld was impaired. This leads to a strong
reduction of the eye morphology at tailbud stage (stage 33/34,
Fig. 6B) and swimming larva (stage 46) 82% (n = 25) display micro-
or anophthalmia (Fig. S5). All of these results are further conﬁrmed by
transverse sections at stage 33/34. Anterior sections revealed that
kcnip1 loss-of-function results in a severe distortion and reduction of
the diencephalon and affects eye morphology as seen by the reduction
of the pigment layer and of the neuroretina (Fig. 6 C1). More posterior
cross-sections passing through otic vesicle showed the impairment of
this structure on the injected side and a reduction of the rhombenceph-
alon, whereas the notochord is not affected (Fig. 6 C2). More caudally,
the symmetry of the embryo is not affected by the suppression of
kcnip1 as shown by the position and the structure of the spinal chord,
the notochord and the presence of pronephric tubules (Fig. 6 C3).
Taken together, these data indicate that the suppression of kcnip1
results in n-tubulin and pax6 down-regulation in anterior neural domain
leading to the impairment of anterior neural development.
4. Discussion
Altogether our data indicate that the neuronal Ca2+ sensor Kcnip1
acts, at the onset of neurogenesis, as a transcriptional repressor to
Fig. 6. Kcnip1 loss of function impacts embryonic development. (A) Injection of MoK1 in one dorsal blastomere of 8-cell embryos, at neurula stage the domain expression of the eye ﬁeld
marker pax6 is reduced when compared with MoC injected embryos. The effect of kcnip1 loss-of-function was analyzed on neuronal differentiation. The anterior domain of n-tub expres-
sion pattern is down-regulated in kcnip1morphants (right panel). (B) At tailbud stage (stage 33/34) kcnip1 loss of function results in the reduction of anterior neural structures and at eye
level (left panel control side, right panelMoK1 injected side *). Transverse sectionswere done according to the indicated lines 1, 2, 3. (C) Rostral transverse sections of hemi-injected stage
33/34 embryos. At eye level (1) revealed that the severe defaults are present at the diencephalon.More posterior cross-sections (2) passing through otic vesicle showed the impairment of
this structure on the injected side, a severe distortion and reduction of the rhombencephalon, whereas the notochord is not affected. More caudally section passing through pronephros
(3), the symmetry of the embryo is not affected by the suppression of kcnip1 as shown by the position of the spinal chord, the notochord and the presence of pronephric tubules).
Abbreviations: e eye, e.f. eye ﬁeld, Di diencephalon, Rh rhombencephalon, n notochord, pt pronephric tubules, and sp spinal chord. Bar 0.5 mm.
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the neural plate.
In Xenopus embryos we show that all four kcnip family members are
expressed but with distinct temporal expression patterns. kcnip1 is
expressed throughout embryonic development and is the only member
that is expressed during gastrulation. ISH analysis conﬁrms that the ec-
toderm expression of kcnip1 starts before the onset of neural induction
and is restricted in the neural territories at later stages. In contrast, in
zebraﬁsh and mouse, the expression pattern of kcnip members are
revealed when brain structures are already formed [19,27].
Among the Kcnip proteins, Kcnip3 has been shown to act in the
nucleus as Ca2+-dependent transcriptional regulator [15,18]. However,
other Kcnip proteins are able to bind to DRE sites and to act as Ca2+-
dependent transcriptional regulators of geneswhose promoters contain
DRE sites, including circadian genes [16], cytokine genes such as IL2, 4
and IFNγ in T lymphocytes [25] and in the thyroid cells pax8 and
foxE1 [22]. In this study, in the amphibian X. laevis embryos during
early neurogenesis, we demonstrate that Kcnip1 possesses a Ca2+-
dependent DRE-binding activity.
According to the cellularmodels, Kcnip proteins have been shown to
positively or negatively affect cell proliferation by controlling cell-cycle
regulators. In murine thyroid cell lines the expression of a dominant ac-
tive mutated Kcnip3, unable to bind Ca2+ and which remains bound to
DNA, decreases thyroid cell proliferation by interferingwith the expres-
sion of cyclin D3 and p27 [22]. In transgenic mice the expression of this
dominant active Kcnip3 triggers hyperplasia of the thyroid gland
through an increased proliferation rate. This proliferative effect is in ac-
cordance with the 2-fold increase of Kcnip3 protein observed in human
multinodular goiters [23]. In B lymphocytes this mutant also triggers
hyperproliferation and the down-regulation of klf9, a cell-cycle regula-
tor required to maintain cells in a quiescent state [26]. Conversely, in T
lymphocytes Kcnip3 is a negative regulator of cell proliferation [25].
Our data show that the loss-of-function of kcnip1 positively controls
proliferation by increasing foxm1 and reducing the cyclin-dependent
kinase inhibitor p27xic1.
During gastrulation and neurulation the neuroectoderm cells prolif-
erate but at a relatively low rate. All neural progenitors divide once dur-
ing this period [47]. Our data show that the loss-of-function of kcnip1
increases the number of proliferating neural precursors, expands the
neural plate at the expense of epidermis as seen by the enlargement
of the anterior expression domain of early neural genes prmt1b, zic3
and sox2 and the inhibition of the epidermis gene k81 and in addition
blocks neuronal differentiation. This phenotype is similar to the over-
expression phenotype observed with sox2 [44].Before gastrulation the ectodermal cells are multipotent and can
give rise either to epidermis or neural tissue. Themechanisms that gov-
ern the choice of neural fate require the inhibition of BMP pathway, the
activation of the FGF and Ca2+ signaling pathways [48]. ISH analysis
shows that kcnip1 is expressed in the dorsal and in the ventral ecto-
derms at early gastrula. How does kcnip1 control the size of the neural
plate? Since we show that the DNA-binding activity of Xenopus Kcnip1
is Ca2+-dependent, we propose that in the dorsal ectoderm the Ca2+
transients are the signals able to release the Kcnip1-dependent repres-
sion of the neural genes prmt1 and sox2while in the ventral ectoderm,
where no Ca2+ transients occurs [5,49], Kcnip1 protein stays bound to
DRE sequences and maintains the repression of its target genes. This
mechanism is further supported by the presence of potential DRE-
binding sites in the regulatory regions of prmt1 and sox2 genes.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.12.007.
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